²é¿´: 465  |  »Ø¸´: 5

18317190548

гæ (СÓÐÃûÆø)


[½»Á÷] ÀàÒ©¶àÑùÐÔ»¯ºÏÎï¿âÔÚÐÂÒ©Ñо¿ÖеÄÓ¦Óà - MedChemExpress

ÀàÒ©¶àÑùÐÔ»¯ºÏÎï¿âÔÚÐÂÒ©Ñо¿ÖеÄÓ¦Óà - MedChemExpress
ÀàÒ©¶àÑùÐԿ⣬¹ËÃû˼Òå,¾ÍÊǼæ¾ßÀàÒ©ÐԺͶàÑùÐԵϝºÏÎï¿â

ÀàÒ©ÐÔ£ºÖ¸»¯ºÏÎïÓëÏÖÓÐÒ©ÎïµÄÏàËÆÐÔ¡£¾ß±¸ÀàÒ©ÐԵϝºÏÎï²»Ò»¶¨ÄܳÉΪҩÎµ«ÊÇÔÚÀí»¯ÐÔÖÊÉϾ߱¸¼«¸ßµÄ³ÉΪҩÎïµÄ¿ÉÄÜÐÔ¡£¾ß±¸ÀàÒ©ÐԵϝºÏÎïÍùÍùÂú×ãÀàÒ©ÎåÔ­Ôò£¨¼´ ¡°Lipinski¡± ÎåÔ­Ôò£©£º


Lipinski ÎåÔ­Ôò£º

·Ö×ÓÁ¿Ð¡ÓÚ 500;

Çâ¼ü¹©ÌåµÄÊýÁ¿²»³¬¹ý 5 ¸ö;

Çâ¼üÊÜÌåµÄÊýÁ¿²»³¬¹ý 10 ¸ö;

»¯ºÏÎïµÄ֬ˮ·ÖÅäϵÊýµÄ¶ÔÊýÖµ (logP) ²»³¬¹ý 5;

»¯ºÏÎïÖпÉÐýת¼üµÄÊýÁ¿²»³¬¹ý 10 ¸ö


ÀàÒ©¶àÑùÐÔ»¯ºÏÎï¿âÔÚÐÂÒ©Ñо¿ÖеÄÓ¦Óà - MedChemExpress-1


ͼ 1. ¡°Lipinski¡± ÎåÔ­Ôò¡£



·ûºÏ ¡°Lipinski¡± Î广ÔòµÄ»¯ºÏÎï»áÓиüºÃµÄÒ©´ú¶¯Á¦Ñ§ÐÔÖÊ£¬ÔÚÉúÎïÌåÄÚ´úл¹ý³ÌÖлáÓиü¸ßµÄÉúÎïÀûÓöȣ¬Òò¶øÒ²¸üÓпÉÄܳÉΪ¿Ú·þÒ©Îï¡£

¶àÑùÐÔ£º»¯ºÏÎï¿âµÄ·Ö×ӽṹ¶àÑùÐÔÊÇʵÏÖÆäÉúÎï»îÐÔ¶àÑùÐԵĻù´¡¡£ÆÀ¼Û»¯ºÏÎï¿â¶àÑùÐÔµÄÖ¸±êÈçÏ£º
¹È±¾ÏàËÆÐÔ£º¹È±¾ÏàËÆÐÔÔ½µÍ£¬´ú±í»¯ºÏÎï¿âµÄ¶àÑùÐÔÔ½¸ß

Fsp3 Öµ£ºFsp3 ´ú±í»¯ºÏÎï sp3 ÔÓ»¯Ì¼ÔªËØÊý/»¯ºÏÎïÌ¼ÔªËØ×ÜÊý£¬ÖµÔ½´ó£¬ËµÃ÷»¯ºÏÎï¿Õ¼äÔ½¸´ÔÓ£¬»¯ºÏÎï¿âµÄ¶àÑùÐÔÔ½¸ß

¹Ç¼Ü¶àÑùÐÔ£º»¯ºÏÎï¿âÖаüº¬µÄ¹Ç¼ÜÀàÐÍÔ½¶à£¬Ôò¶àÑùÐÔÔ½¸ß
¹ÙÄÜÍŶàÑùÐÔ

È¡´ú»ù¶àÑùÐÔ

Á¢Ì廯ѧ¶àÑùÐÔ



ÀàÒ©¶àÑùÐÔ»¯ºÏÎï¿âÔÚÐÂÒ©Ñо¿ÖеÄÓ¦Óà - MedChemExpress-2

Ê×ÏÈ£¬ËüÍ»ÆÆÁË´´ÐÂÄ¿±ê: ÀàÒ©¶àÑùÐÔ»¯ºÏÎï¿âÖ¼ÔÚ̽Ë÷ÒÔǰδ±»·¢¾òµÄ»¯ºÏÎï½á¹¹£¬°ïÖúÑо¿ÈËÔ±¿ÉÒÔѰÕÒµ½¸üÓÐЧ¡¢¸ü¾ßÑ¡ÔñÐÔµÄÐÂÒ©Ä¿±ê¡£

ÕâÖÖÒÔ´´ÐÂÐÔΪÇý¶¯µÄɸѡ¿ÉÒÔÍÆ¶¯ÐÂÒ©Ñз¢µÄÍ»ÆÆ£¬ÎªÖÎÁÆÄÇЩ¹ýÈ¥ÎÞ·¨½â¾öµÄ¼²²¡´øÀ´ÐµĿÉÄÜÐÔ¡£

µÚ¶þ£¬ËüÒ×ÓÚÒ©ÎïÎïÐÔÓÅ»¯: ÀàÒ©¶àÑùÐÔ»¯ºÏÎï¿âµÄ¹ÙÄÜÍŶàÑùÐÔʹÑо¿ÈËÔ±Äܹ»Õë¶ÔÒ©Îï·Ö×ÓµÄÌØ¶¨ÐÔÖʽøÐÐÓÅ»¯¡£»ùÓÚ¿âÖл¯ºÏÎïµÄ¹ã·º»¯Ñ§¿Õ¼ä£¬Ñо¿ÈËÔ±¿ÉÒÔ²âÊÔ¸÷ÖÖ¹ÙÄÜÍŶÔÒ©ÎïÎüÊÕ¡¢·Ö²¼¡¢´úлºÍÅÅй£¨ADME£©ÐÔÖʵÄÓ°Ï죬ÓÐÖúÓÚÌá¸ßÒ©ÎïµÄÉúÎïÀûÓöȺÍÎȶ¨ÐÔ£¬ÔöǿҩÎïµÄÁÙ´²Ð§¹û¡£

ÀàÒ©¶àÑùÐÔ»¯ºÏÎï¿âÔÚÐÂÒ©Ñо¿ÖеÄÓ¦Óà - MedChemExpress-3


ͼ 2. »ùÓڹ㷺»¯Ñ§¿Õ¼äµÄ¸ßЧɸѡ[1]¡£



×îºó£¬ÀàÒ©¶àÑùÐÔ»¯ºÏÎï¿âÀûÓÚ¸ßЧɸѡ: ÀàÒ©¶àÑùÐÔ»¯ºÏÎï¿âµÄ¹ã·º»¯Ñ§¿Õ¼äΪ¸ßЧɸѡÌṩ½á¹¹»ù´¡¡£Ñо¿ÈËÔ±¿ÉÒÔ´Ó¿âÖпìËÙɸѡ´óÁ¿µÄ»¯ºÏÎ²¢ÆÀ¹ÀËüÃÇÓëÌØ¶¨¼²²¡°ÐµãÖ®¼äµÄÏ໥×÷Óá£

ÕâÖÖ¸ßͨÁ¿É¸Ñ¡·½·¨Äܹ»Ñ¸ËÙʶ±ðDZÔڵĻîÐÔ»¯ºÏÎÌá¸ßÒ©Îï·¢ÏÖµÄЧÂÊ£¬ÎªÐÂÒ©Ñз¢ÌṩÓÐЧµÄºòÑ¡Îï¡£

ÀàÒ©¶àÑùÐÔ»¯ºÏÎï¿âÔÚÐÂÒ©Ñо¿ÖеÄÓ¦Óà - MedChemExpress-4


ÀàÒ©¶àÑùÐÔ»¯ºÏÎï¿âÔÚÐÂÒ©Ñо¿ÖеÄÓ¦Óà - MedChemExpress-5


Kelly L. Johnston µÈÈ˹¹½¨ÁË Wolbachia ¸ÐȾµÄ C6/36 ϸ°ûÄ£ÐÍ£¬¶Ôº¬ÓÐ 10000 ¸ö»¯ºÏÎïµÄ¶àÑùÐÔ»¯ºÏÎï¿â½øÐÐÁËɸѡ£¬Ï£ÍûÕÒµ½Äܹ»¾ßÓп¹ÎÖ¶û°Í¿ËÊÏÌå»îÐÔµÄÒ©Îͨ¹ýÏÔ΢¾µ¹Û²ìϸ°ûÈں϶ÈÀ´ÆÀ¹ÀÖ±½Óϸ°û¶¾ÐÔ£¬½á¹û´Óº¬ÓÐ 10000 ¸ö»¯ºÏÎïµÄ¶àÑùÐÔ¿âÖÐɸѡ³öÀ´ÁË 50 ¸ö¿¹ÎÖ¶û°Í¿ËÊÏÌåÒ©Î´ïµ½ÁË 0.5% µÄÃüÖÐÂÊ[2]¡£

ÀàÒ©¶àÑùÐÔ»¯ºÏÎï¿âÔÚÐÂÒ©Ñо¿ÖеÄÓ¦Óà - MedChemExpress-6


ͼ 3. »ùÓÚ¶àÑùÐÔ»¯ºÏÎï¿âµÄ¿¹ Wolbachia Ò©ÎïɸѡÁ÷³Ì[2]¡£



ÀàÒ©¶àÑùÐÔ»¯ºÏÎï¿âÔÚÐÂÒ©Ñо¿ÖеÄÓ¦Óà - MedChemExpress-7


Matthew Abraham µÈÈËÆÀ¹ÀÁËÀ´×Ô GHCDL ¶àÑùÐÔ»¯ºÏÎï¿âµÄ 68,614 ÖÖ»¯ºÏÎï¶Ô²»Í¬Éú³¤Ê±ÆÚµÄű¼²¼ÄÉú³æµÄ»îÐÔÓ°Ï죬·¢ÏÖÔÚÕâ 68,614 ¸ö»¯ºÏÎïÖдæÔÚ 382 ÖÖ¾ßÓнÏÇ¿¿¹Å±»îÐÔ(IC50<10 ¦ÌM)µÄ»¯ºÏÎï¹Ç¼Ü£¬»¹ÓÐÁùÖֹǼܾßÓм«Ç¿µÄÒÖÖÆ»îÐÔ(IC50<1 ¦ÌM)[3]¡£ÕâÏîÑо¿¼«´óµØÍ»³öÁË»¯ºÏÎï¹Ç¼Ü·á¸»¶àÑùµÄÀàÒ©»¯ºÏÎïÔÚÐÂÒ©Ñз¢ÉϵÄÓÅÊÆ¡£

ÀàÒ©¶àÑùÐÔ»¯ºÏÎï¿âÔÚÐÂÒ©Ñо¿ÖеÄÓ¦Óà - MedChemExpress-8


ͼ 4. »ùÓÚ GHCDL ¶àÑùÐÔ»¯ºÏÎï¿âµÄ¿¹Å±»îÐÔɸѡ[3]¡£


MCEµÄËùÓвúÆ·½öÓÃ×÷¿ÆÑ§Ñо¿»òÒ©Ö¤É걨£¬ÎÒÃDz»ÎªÈκθöÈËÓÃ;Ìṩ²úÆ·ºÍ·þÎñ¡£

²Î¿¼ÎÄÏ×£º
[1] Probst D, et al. Exploring DrugBank in Virtual Reality Chemical Space. J Chem Inf Model. 2018 Sep 24;58(9):1731-1735. 
[2] Johnston, K. L. et al. Identification and prioritization of novel anti-wolbachia chemotypes from screening a 10,000-compound diversity library. Science Advances, (2017). 3(9), eaao1551.
[3] Abraham M, et al. Probing the Open Global Health Chemical Diversity Library for Multistage-Active Starting Points for Next-Generation Antimalarials. ACS Infect Dis. 2020 Apr 10;6(4):613-628. 
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)

» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:

²é¿´È«²¿É¢½ðÌù

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
¼òµ¥»Ø¸´
2024-02-19 16:49   »Ø¸´  
18317190548(½ð±Ò+1): лл²ÎÓë
nono20093Â¥
2024-02-19 18:03   »Ø¸´  
18317190548(½ð±Ò+1): лл²ÎÓë
¡¤
tzynew4Â¥
2024-02-19 19:55   »Ø¸´  
18317190548(½ð±Ò+1): лл²ÎÓë
k ·¢×ÔСľ³æAndroid¿Í»§¶Ë
2024-02-19 21:25   »Ø¸´  
18317190548(½ð±Ò+1): лл²ÎÓë
shenrenren6Â¥
2024-02-20 07:10   »Ø¸´  
18317190548(½ð±Ò+1): лл²ÎÓë
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ 18317190548 µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 301Çóµ÷¼Á +10 ³¯Ìì½·µÄË«Âíβ 2026-03-05 10/500 2026-03-08 10:12 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] ²ÄÁÏ325Çóµ÷¼Á 30+6 mariusuki 2026-03-02 12/600 2026-03-07 20:12 by xindong
[¿¼ÑÐ] 289Çóµ÷¼Á +10 yangæÃ 2026-03-02 12/600 2026-03-07 17:34 by һͷ¿ªÐĵĸç˹À
[¿¼ÑÐ] Ò»Ö¾Ô¸ÖÐʯÓÍ£¬»¯Ñ§¹¤³Ì£¬301Çóµ÷¼Á +4 ëàÂøè×è× 2026-03-04 4/200 2026-03-06 22:15 by ÐÇ¿ÕÐÇÔÂ
[¿¼ÑÐ] 0703 ¶«»ª´óѧ Àíѧ»¯Ñ§¾ù¹ý a Ïߣ¬×Ü·Ö 281 Çóµ÷¼Á +6 ÏãÏã Lu 2026-03-03 11/550 2026-03-06 15:37 by @ìªìªìªìª
[¿¼ÑÐ] 332²ÄÁÏÇóµ÷¼Á +6 zjy101327 2026-03-05 7/350 2026-03-06 00:18 by wutongshun
[¿¼ÑÐ] Çóµ÷¼Á£¬Ñ§Ð£Ñо¿Ëù¶¼¿ÉÒÔ£¬²ÄÁÏÓ뻯¹¤267·Ö +6 wmx1 2026-03-05 6/300 2026-03-05 20:01 by houyaoxu
[¿¼ÑÐ] 085602 293·ÖÇóµ÷¼Á +3 SivanNano. 2026-03-05 3/150 2026-03-05 19:41 by caszguilin
[¿¼ÑÐ] 304Çóµ÷¼Á +3 ÂüÊâ2266 2026-03-04 3/150 2026-03-05 10:39 by Iveryant
[¿¼ÑÐ] 085701»·¾³¹¤³Ì Çóµ÷¼Á +7 xiiiia 2026-03-04 7/350 2026-03-05 09:49 by ÈÈÇéɳĮ
[¿¼ÑÐ] ²ÄÁÏѧ˶080500¸´ÊÔµ÷¼Á294 +3 ËÄÒ¶zjz 2026-03-04 3/150 2026-03-05 07:09 by kunm555
[¿¼ÑÐ] Äܶ¯297Çóµ÷¼Á£¬±¾¿Æ´¨´ó +4 ÉÛ11 2026-03-04 4/200 2026-03-04 15:29 by lylylyheart
[¿¼ÑÐ] 085601 ²ÄÁÏ305·ÖÇóÖú +4 ÅÝÅÝÓʼþ 2026-03-03 6/300 2026-03-04 13:00 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] ²ÄÁϹ¤³Ì269Çóµ÷¼Á +7 °×´Ìõ 2026-03-02 7/350 2026-03-04 08:47 by zhyzzh
[¿¼ÑÐ] »·¾³¹¤³Ìѧ˶288ÇóÖúµ÷¼Á +7 ¶à³ÔÒÚ¿Ú֥ʿ 2026-03-02 7/350 2026-03-03 23:00 by zhukairuo
[¿¼ÑÐ] »¯¹¤×¨Ë¶µ÷¼Á +4 ÀûºÃÀûºÃ. 2026-03-03 7/350 2026-03-03 21:30 by L135790
[¿¼ÑÐ] Ò»Ö¾Ô¸¶«±±´óѧ»¯Ñ§314·ÖÇóµ÷¼Á +5 lr1212.. 2026-03-02 5/250 2026-03-03 15:26 by xingtian2025
[¿¼ÑÐ] Ò»Ö¾Ô¸ÖпƴóÄܶ¯297Çóµ÷¼Á£¬±¾¿Æ´¨´ó +3 ÉÛ11 2026-03-03 3/150 2026-03-03 14:50 by ÐÂÄÜÔ´´ïÈË
[¿¼ÑÐ] »¯Ñ§0703Çóµ÷¼Á ѧ˶ Àí/¹¤¿Æ¾ù¿É ×Ü·Ö279 +3 1Ò»11 2026-03-03 5/250 2026-03-03 12:37 by 1Ò»11
[¿¼ÑÐ] 322Çóµ÷¼Á +3 Ðܾ³†´ 2026-03-01 3/150 2026-03-02 08:44 by houyaoxu
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û